19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Fell–Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Heparan sulphate ( HS) sits at the interface of the cell and the extracellular matrix. It is a member of the glycosaminoglycan family of anionic polysaccharides with unique structural features designed for protein interaction and regulation. Its client proteins include soluble effectors (e.g. growth factors, morphogens, chemokines), membrane receptors and cell adhesion proteins such as fibronectin, fibrillin and various types of collagen. The protein‐binding properties of HS, together with its strategic positioning in the pericellular domain, are indicative of key roles in mediating the flow of regulatory signals between cells and their microenvironment. The control of transmembrane signalling is a fundamental element in the complex biology of HS. It seems likely that, in some way, HS orchestrates diverse signalling pathways to facilitate information processing inside the cell. A dictionary definition of an orchestra is ‘a large group of musicians who play together on various instruments …’ to paraphrase, the HS orchestra is ‘a large group of proteins that play together on various receptors’. HS conducts this orchestra to ensure that proteins hit the right notes on their receptors but, in the manner of a true conductor, does it also set ‘the musical pulse’ and create rhythm and harmony attractive to the cell? This is too big a question to answer but fun to think about as you read this review.

          Related collections

          Most cited references202

          • Record: found
          • Abstract: found
          • Article: not found

          Demystifying heparan sulfate-protein interactions.

          Numerous proteins, including cytokines and chemokines, enzymes and enzyme inhibitors, extracellular matrix proteins, and membrane receptors, bind heparin. Although they are traditionally classified as heparin-binding proteins, under normal physiological conditions these proteins actually interact with the heparan sulfate chains of one or more membrane or extracellular proteoglycans. Thus, they are more appropriately classified as heparan sulfate-binding proteins (HSBPs). This review provides an overview of the various modes of interaction between heparan sulfate and HSBPs, emphasizing biochemical and structural insights that improve our understanding of the many biological functions of heparan sulfate.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.

            The crystal structure of a dimeric 2:2:2 FGF:FGFR:heparin ternary complex at 3 A resolution has been determined. Within each 1:1 FGF:FGFR complex, heparin makes numerous contacts with both FGF and FGFR, thereby augmenting FGF-FGFR binding. Heparin also interacts with FGFR in the adjoining 1:1 FGF:FGFR complex to promote FGFR dimerization. The 6-O-sulfate group of heparin plays a pivotal role in mediating both interactions. The unexpected stoichiometry of heparin binding in the structure led us to propose a revised model for FGFR dimerization. Biochemical data in support of this model are also presented. This model provides a structural basis for FGFR activation by small molecule heparin analogs and may facilitate the design of heparin mimetics capable of modulating FGF signaling.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.

              During organogenesis, immunosurveillance, and inflammation, chemokines selectively recruit leukocytes by activating seven-transmembrane-spanning receptors. It has been suggested that an important component of this process is the formation of a haptotactic gradient by immobilization of chemokines on cell surface glycosaminoglycans (GAGs). However, this hypothesis has not been experimentally demonstrated in vivo. In the present study we investigated the effect of mutations in the GAG binding sites of three chemokines, monocyte chemoattractant protein-1/CC chemokine ligand (CCL)2, macrophage-inflammatory protein-1beta/CCL4, and RANTES/CCL5, on their ability to recruit cells in vivo. These mutant chemokines retain chemotactic activity in vitro, but they are unable to recruit cells when administered intraperitoneally. Additionally, monomeric variants, although fully active in vitro, are devoid of activity in vivo. These data demonstrate that both GAG binding and the ability to form higher-order oligomers are essential for the activity of particular chemokines in vivo, although they are not required for receptor activation in vitro. Thus, quaternary structure of chemokines and their interaction with GAGs may significantly contribute to the localization of leukocytes beyond migration patterns defined by chemokine receptor interactions.
                Bookmark

                Author and article information

                Journal
                Int J Exp Pathol
                Int J Exp Pathol
                10.1111/(ISSN)1365-2613
                IEP
                International Journal of Experimental Pathology
                John Wiley and Sons Inc. (Hoboken )
                0959-9673
                1365-2613
                15 July 2015
                August 2015
                : 96
                : 4 ( doiID: 10.1111/iep.2015.96.issue-4 )
                : 203-231
                Affiliations
                [ 1 ] Cancer Research UK Manchester InstituteInstitute of Cancer Sciences Paterson Building University of Manchester ManchesterUK
                Author notes
                [*] [* ] Correspondence:

                John Gallagher

                Iduron Ltd.,

                BioHub

                Alderley Park

                Alderley Edge

                Cheshire SK10 4TG

                UK

                E‐mail: john@ 123456iduron.co.uk

                Article
                IEP12135
                10.1111/iep.12135
                4561558
                26173450
                36d1a669-f434-4b9f-af28-909802f0d91e
                © 2015 The Authors. International Journal of Experimental Pathology published by John Wiley & Sons Ltd on behalf of Company of the International Journal of Experimental Pathology (CIJEP).

                This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 19 December 2014
                : 22 May 2015
                Page count
                Pages: 29
                Funding
                Funded by: Cancer Research UK
                Funded by: MRC
                Funded by: Wellcome Trust
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                iep12135
                August 2015
                Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.1 mode:remove_FC converted:21.06.2016

                Pathology
                glycosaminoglycan,heparan sulphate,heparan sulphate/heparin
                Pathology
                glycosaminoglycan, heparan sulphate, heparan sulphate/heparin

                Comments

                Comment on this article